These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 323422)

  • 1. 6-hydroxydopamine destruction of central adrenergic neurones prevents or reverses developing DOCA-salt hypertension in rats.
    Lamprecht F; Richardson JS; Williams RB; Kopin IJ
    J Neural Transm; 1977; 40(2):149-58. PubMed ID: 323422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central and peripheral adrenergic mechanisms in the development of deoxycorticosterone-saline hypertension in rats.
    Reid JL; Zivin JA; Kopin IJ
    Circ Res; 1975 Nov; 37(5):569-79. PubMed ID: 1192556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of intraventricular and intraspinal 6-hydroxydopamine on blood pressure of DOCA-saline hypertensive rats.
    Kubo T; Hashimoto M
    Arch Int Pharmacodyn Ther; 1979 Mar; 238(1):50-9. PubMed ID: 485704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the role of the septal area in the development of DOCA-salt hypertension in the rat.
    Richardson JS
    Clin Exp Hypertens A; 1983; 5(3):469-78. PubMed ID: 6839515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central catecholamine depletion, vasopressin, and blood pressure in the DOCA/NaCl rat.
    Okuno T; Winternitz SR; Lindheimer MD; Oparil S
    Am J Physiol; 1983 Jun; 244(6):H807-13. PubMed ID: 6407335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in responsiveness of noradrenergic neurons of the locus coeruleus in deoxycorticosterone acetate (DOCA)-salt hypertensive rats.
    Berecek KH; Olpe HR; Mah SC; Hofbauer KG
    Brain Res; 1987 Jan; 401(2):303-11. PubMed ID: 2880643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of presynaptic beta 2-adrenergic facilitation in the development and maintenance of DOCA-salt hypertension.
    Moreau P; Drolet G; Yamaguchi N; de Champlain J
    Am J Hypertens; 1993 Dec; 6(12):1016-24. PubMed ID: 7907884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurotransmitter release, vascular responsiveness and their suppression by Ca-antagonist in perfused mesenteric vasculature of DOCA-salt hypertensive rats.
    Tsuda K; Kuchii M; Nishio I; Masuyama Y
    Clin Exp Hypertens A; 1986; 8(2):259-75. PubMed ID: 3720003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the renal nerves in the maintenance of DOCA-salt hypertension in the rat. Influence on the renal vasculature and sodium excretion.
    Katholi RE; Naftilan AJ; Bishop SP; Oparil S
    Hypertension; 1983; 5(4):427-35. PubMed ID: 6345357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central adrenergic neurons in DOCA-salt hypertension.
    Lamprecht F; Jacobowitz DM; Richardson JS; Kopin IJ
    J Neurosci Res; 1975; 1(3-4):227-34. PubMed ID: 1225988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in renal and central noradrenergic activity with potassium in DOCA-salt rats.
    Fujita T; Sato Y
    Am J Physiol; 1984 May; 246(5 Pt 2):F670-5. PubMed ID: 6144278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of norepinephrine release from vascular adrenergic neurons by oral administration of beta-blocker in DOCA-salt hypertension.
    Tsuda K; Masuyama Y
    Am J Hypertens; 1991 Jan; 4(1 Pt 1):68-71. PubMed ID: 2007000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain catecholamines during development of DOCA-salt hypertension in rats.
    Saavedra JM
    Brain Res; 1979 Dec; 179(1):121-7. PubMed ID: 509225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebral intraventricular 6-hydroxydopamine prevents vascular changes in the mineralocorticoid hypertensive rat.
    Mecca TE; Lamb FS; Hall JL; Webb RC
    Proc Soc Exp Biol Med; 1985 Jun; 179(2):248-53. PubMed ID: 3921975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retardation of the development of hypertension in DOCA-salt rats by renal denervation.
    Takahashi H; Iyoda I; Yamasaki H; Takeda K; Okajima H; Sasaki S; Yoshimura M; Nakagawa M; Ijichi H
    Jpn Circ J; 1984 Jun; 48(6):567-74. PubMed ID: 6547490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade of angiotensin receptors in the anterior hypothalamic preoptic area lowers blood pressure in DOCA-salt hypertensive rats.
    Kubo T; Yamaguchi H; Tsujimura M; Hagiwara Y; Fukumori R
    Hypertens Res; 2000 Mar; 23(2):109-18. PubMed ID: 10770257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of chloride in the sympathetic nervous system in DOCA-salt hypertension.
    Motoyama T; Sano H; Miki T; Suzuki H; Kawaguchi K; Furuta Y; Fukuzaki H
    Am J Hypertens; 1988 Jul; 1(3 Pt 1):287-90. PubMed ID: 3390322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overflow of endogenous norepinephrine from PVH nucleus of DOCA-salt hypertensive rats.
    Qualy JM; Westfall TC
    Am J Physiol; 1995 Apr; 268(4 Pt 2):H1549-54. PubMed ID: 7733356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dependence of deoxycorticosterone/salt hypertension in the rat on the activity of adrenergic cardiac nerves.
    Bell C; McLachlan EM
    Clin Sci (Lond); 1979 Aug; 57(2):203-10. PubMed ID: 38942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic treatment with mianserin prevents DOCA-salt hypertension in rats--evidence for the involvement of central 5-HT2 receptors.
    Silva AL; Cabral AM; Abreu GR; Pires JG; Bissoli NS; Ramage AG
    Eur J Pharmacol; 2005 Aug; 518(2-3):152-7. PubMed ID: 16014306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.